This blend combines three distinct mechanisms of action: tesa's growth hormone-releasing hormone (GHRH) analog properties, CJC1295's extended half-life characteristics, and ipamorelin's selective growth hormone secretagogue receptor activation
Cell Biochem Biophys 66:431441
TB500 has garnered attention for its potential in a variety of medical applications, including aiding in muscle and tendon repair, reducing inflammation, and promoting wound healing
Licensed alternatives for weight management, including semaglutide (Wegovy) and liraglutide (Saxenda), are available through regulated NHS and private pathways following NICE appraisal
Prasad, R
Scieglinska, D., Piglowski, W., Chekan, M., Mazurek, A